Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

Finasteride reduces movement issues in Parkinson's disease rats.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Niosomes are a promising and effective way to deliver drugs through the skin.

Minoxidil boosts elastin production, potentially helping skin diseases.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Finasteride can treat prostatic haematuria, but its use is controversial.

Minoxidil slows down keratinocyte growth without being toxic.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

The anti-ageing treatment market is growing by exploiting fears of ageing with unproven promises, which could harm public trust and genuine science.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Young women with PCOS without additional risk factors may have normal heart function.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Minoxidil increased small openings in blood vessel walls near growing hair in rats.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.